Review
Copyright ©The Author(s) 2023.
World J Hepatol. Oct 27, 2023; 15(10): 1091-1108
Published online Oct 27, 2023. doi: 10.4254/wjh.v15.i10.1091
Table 1 Flavonoids improve hepatic fibrosis by inhibiting oxidative stress
No.
Flavonoids
Model
Upregulated molecules
Downregulated molecules
Mechanism
Ref.
1Mallotus apelta (Lour.) Muell.Arg. leafRatIkBa, SOD, GSH-PxHYP, PC-III, Col-I, HA, LN, α-SMA, Col-III, MDA, TNF-α, IL-1β, IL-6, MMP-2/9, TIMP-1, TGF-β1/Smad, IKKβ, NF-κB p65, pNF-κBp65, IκBα, p-IκBαImproving hepatic fibrosis and reducing ECM accumulation are related to inhibiting OS and regulating the TGF-β1/Smad signaling pathway and NF-κB-dependent inflammatory responseZhang et al[117]
2Bidens bipinnata L.RatSOD, GSH-PxNF-κB, α-SMA, TGF-β1Inhibiting OS to improve liver injury and protect rats from CCl4-induced hepatic fibrosisYuan et al[118]
3PuerarinRatSOD, CATTG, TCHO, LDL, α-SMA, Col-I/III, MDA, IL-1β, IL-6, TNF-α, MCP-1, NF-κB/p65, TGF-β, TGF-β/Smad2/3Inhibiting OS and inflammation associated with NF-κB signal inactivation, thereby blocking the upregulation of pro-inflammatory cytokines (IL-1β and TNF-α) and chemokines (MCP-1), ultimately improving hepatic fibrosisHou et al[119]
4HesperidinMiceROSRegulating liver OS and alleviating mitochondrial dysfunction to reduce fibrosisLi et al[120]
5AlpinetinMiceIL-10, CAT, GSH-Px, SOD, GSH, Nrf2HYP, α-SMA, fibronectin, α1(I) procollagen, IL-1β, IL-6, TNF-α, Cox-2, iNOS, MDA, VEGF, VEGFR2, PDGF-βR, HIF-1αPreventing and treating hepatic fibrosis by inhibiting the anti-inflammatory activity mediated by NLRP3 and the anti-OS activity mediated by Nrf2Zhu et al[121]
6FisetinRatGSH, GSK-3βMDA, TNF-α, IL-6, TGF-β1, Col-I, TIMP-1, Wnt3a, β-catenin, α-SMA, Cyclin D1Inhibiting liver OS can suppress Wnt/β-catenin pathway and inhibit HSC activation and proliferation, regulate MMP-9 and TIMP-1, and suppress multiple pro-fibrotic factors, to prevent and treat hepatic fibrosisEl-Fadaly et al[122]
7GlabridinMicePPAR-γ, GSH, T-AOCα-SMA, fibronectin, Col-α1(I), MDAActivation of PPARγ can inhibit inflammation and OS, thereby inhibiting HSC activation and hepatic fibrosisZhang et al[123]
8MorinRatGSHNO, HYP, TNF-α, iNOS, NF-κB (p65)Receiving MDA and nitric oxide levels elevation, and restoring GSH to normal levels can inhibit OS and improve hepatic fibrosisHeeba and Mahmoud[124]
9AstilbinRatSOD, GSH, GCLC, GCLM, HO-1, NQO1, Nrf2TGF-β, Col-I/III, HYP, TNF-α, IL-1β, IL-6, MDASignificant reduction in collagen production, inflammation and OS in vivo can prevent CCL4-induced hepatic fibrosis in ratsSun et al[125]